dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Garrido‑Cumbrera, M. |
dc.contributor.author | Santos‑Lasaosa, S. |
dc.contributor.author | Aguirre‑Vazquez, M. |
dc.contributor.author | Correa‑Fernández, J. |
dc.contributor.author | Colomina, I. |
dc.contributor.author | Pozo Rosich, Patricia |
dc.contributor.author | Irimia, Pablo |
dc.date.accessioned | 2021-11-29T10:46:58Z |
dc.date.available | 2021-11-29T10:46:58Z |
dc.date.issued | 2021-04-15 |
dc.identifier.citation | Irimia P, Garrido-Cumbrera M, Santos-Lasaosa S, Aguirre-Vazquez M, Correa-Fernández J, Colomina I, et al. Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas. Sci Rep. 2021 Apr 15;11:8286. |
dc.identifier.issn | 2045-2322 |
dc.identifier.uri | https://hdl.handle.net/11351/6618 |
dc.description | Neuroscience; Psychology |
dc.description.abstract | Identifying highly disabled patients or at high risk of psychiatric comorbidity is crucial for migraine management. The burden of migraine increases with headache frequency, but the number of headache days (HDs) per month after which disability becomes severe or the risk of anxiety and depression is higher has not been established. Here, we estimate the number of HDs per month after which migraine is associated with higher risk of anxiety and depression, severe disability and lower quality of life. We analysed 468 migraine patients (mean age 36.8 ± 10.7; 90.2% female), of whom 38.5% had ≥ 15 HDs per month. Our results show a positive linear correlation between the number of HDs per month and the risk of anxiety (r = 0.273; p < 0.001), depression (r = 0.337; p < 0.001) and severe disability (r = 0.519; p < 0.001). The risk of anxiety is higher in patients having ≥ 3HDs per month, and those with ≥ 19HDs per month are at risk of depression. Moreover, patients suffering ≥ 10HDs per month have very severe disability. Our results suggest that migraine patients with ≥ 10HDs per month are very disabled and also that those with ≥ 3HDs per month should be screened for anxiety. |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | Scientific Reports;11 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Migranya - Epidemiologia - Espanya |
dc.subject | Discapacitats - Psicologia |
dc.subject.mesh | Migraine Disorders |
dc.subject.mesh | /epidemiology |
dc.subject.mesh | Spain |
dc.subject.mesh | Disabled Persons |
dc.title | Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41598-021-87352-2 |
dc.subject.decs | trastornos migrañosos |
dc.subject.decs | /epidemiología |
dc.subject.decs | España |
dc.subject.decs | personas con discapacidad |
dc.relation.publishversion | https://doi.org/10.1038/s41598-021-87352-2 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Irimia P] Department of Neurology, Clínica Universidad de Navarra, Av. Pío XII 36, 31008 Pamplona, Spain. Navarra’s Health Research Institute (IDISNA), Pamplona, Spain. Headache Study Group of the Spanish Neurological Society (GECSEN), Pamplona, Spain. [Garrido-Cumbrera M, Correa-Fernández J] Health and Territory Research (HTR), Universidad de Sevilla, Sevilla, Spain. [Santos-Lasaosa S] Headache Study Group of the Spanish Neurological Society (GECSEN), Pamplona, Spain. Department of Neurology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain. Instituto de Investigación Sanitaria IIS Aragón, Zaragoza, Spain. [Aguirre-Vazquez M] Novartis Farmacéutica Spain, Barcelona, Spain. [Colomina I] Spanish Patient’s Association of Migraine and Headache (AEMICE), Madrid, Spain. [Pozo-Rosich P] Headache Study Group of the Spanish Neurological Society (GECSEN), Pamplona, Spain. Unitat de Cefalea, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca en Cefalea (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 33859216 |
dc.identifier.wos | 000641844600042 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |